|
Richard Trevillion was appointed Chief Executive Officer of BioProgress plc in February 2005, with significant experience in pharmaceuticals, healthcare and corporate finance. Prior this appointment, he was the founder, Chief Executive Officer and a Non-Executive Director of Amity Partners Limited, a healthcare and technology finance business. Before Amity, he was Head of Healthcare within the Technology Corporate Finance Group at Close Brothers and previously Co-Director at Arthur Andersen responsible for its healthcare corporate finance team. He began his career with law firms Lovell White Durrant and Simmons & Simmons where he qualified as a solicitor. He has advised, invested in and run a number of healthcare companies in both the UK and the US. | 